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Translating Best Evidence into Best Care
EDITOR’S NOTE: Studies for this column are identified using the Clinical Queries feature of PubMed, “hand” searching JAMA,
JAMA Pediatrics, Pediatrics, The Journal of Pediatrics, and The New England Journal of Medicine, and from customized
EvidenceUpdates alerts.
EBM PEARL: NONINFERIORITY TRIAL: Anoninferiority trial compares a new treatment that offers a nontherapy-
based advantage over the current effective treatment. The advantage may be less toxicity, decreased cost, ease
of use, or other benefits. However, investigators of noninferiority studies are not interested in determining potential
therapeutic superiority over the current treatment. The new treatment demonstrates its preferred use if it is, at least,
not clinically worse than the current treatment. Study investigators must state at the outset of the study how much
worse the new treatment could be and still be considered clinically effective (eg, 10% worse). If the study results
demonstrate that the new treatment’s 95% CI lower limit exceeds the predetermined efficacy cutoff, the new treat-
ment is deemed noninferior. An example is highlighted in the piece by Ashkenazi on page 303 regarding the article
by Freedman et al (JAMA 2016;315:1966-74). The investigators picked 7.5% worse as the cutoff for rehydration
failure. In fact, the new treatment (dilute apple juice) was not only noninferior, it was actually superior to treatment
with oral electrolyte solution.
LITERATURE SEARCH PEARL: HTA DATABASE CANADIAN REPOSITORY: Health technology as-
sessment (HTA) is a process that systematically summarizes information on medical, economic, ethical, and social
effects related to health technology. Introduced in 2015, the HTADatabase Canadian Repository (www.crd.york.ac.uk/
PanHTA) is a freely available electronic storehouse of Canadian, British, and international HTA reports. The United
Kingdom’s National Institute for Health Research sponsors the Database, and the University of York Centre for
Reviews and Dissemination administers it. Many HTA Database reports (eg, economic health analyses, in-
progress reports) are typically found only in the gray literature. The HTA Database links to the Database of Ab-
stracts of Reviews of Effects, the Cochrane reviews, the National Health Service Economic Evaluation Database
of assessed economic evaluations, and others. Depending on the specific source, some reports are critically ap-
praised and others are not. Records in languages other than English are translated.
– Jordan Hupert, MD
Dilute apple juice superior to electrolyte
solution in mild dehydration
Freedman SB, Willan AR, Boutis K, Schuh S. Effect of Dilute
Apple Juice and Preferred Fluids vs Electrolyte Maintenance
Solution on Treatment Failure Among Children With Mild
Gastroenteritis: A Randomized Clinical Trial. JAMA
2016;315:1966-74.
Question Is dilute apple juice noninferior to electrolyte so-
lution in treating gastroenteritis?
Design Randomized, single-blind noninferiority trial.
Setting Pediatric emergency department in Toronto, Canada.
Participants Children with minimal dehydration, aged 6-60
months, with gastroenteritis.
Intervention Half-strength apple juice followed by preferred
fluid versus apple-flavored electrolyte maintenance solution.
Outcomes Treatment failure defined as any of: intravenous re-
hydration, hospitalization, subsequent unscheduled physi-
cian encounter, protracted symptoms, crossover, 3% or more
weight loss, or significant dehydration at follow-up.
Noninferiority margin: 7.5% difference.
Main Results Dilute apple juice followed by preferred fluid
was superior to electrolyte maintenance solution, absolute risk
reduction 8.3% (97.5% CI, 2.0%-∞), number needed to treat
12 (97.5% CI, 0-50).
Conclusions Treatment with dilute apple juice was superior
to electrolyte solution.
Commentary Oral rehydration solutions (ORS), physiologi-
cally based on glucose-coupled sodium absorption (~1:1
glucose:sodium), is advocated by both US1 and European2
guidelines to prevent and treat dehydration. Due to their high
carbohydrate and low sodium content, fruit juices and soft
drinks are discouraged1,2 because the carbohydrates are in-
completely absorbed, leading to augmented diarrhea and some-
times to hyponatremia.3 This well-conducted, comparative study
demonstrated that dilute apple juice followed with preferred
fluids was not only noninferior, but superior to electrolyte
maintenance solution in children with mild gastroenteritis. The
key significant difference was the need for IV rehydration.
However, children included had a mean age of 28 months and
presented with no (68%) or minimal (32%) evidence of de-
hydration. The beneficial effect was greater among children
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older than 24 months of age, who are, based on my experi-
ence, more likely to refuse ORS. The evidence may be trans-
lated to patient care with caution and certain limitations. This
approach can be considered in older children (>24 months of
age) living in high-income locations with no or minimal de-
hydration. Apparently in these settings, as juice-fed children
consume more fluid and calories with higher weight gain,3 the
increased fluid and energy intake outweighs the carbohy-
drate load of the feeding solution.




1. American Academy of Pediatrics. Statement of endorsement: managing acute
gastroenteritis among children: oral rehydration maintenance and nutri-
tional therapy. Pediatrics 2004;114:507.
2. Guarino A, Ashkenazi S, Gendrel D, Lo Vecchio A, Shamir R, Szajewska
H, et al. European Society for Pediatric Gastroenterology, Hepatology and
Nutrition/European Society for Paediatric Infectious Diseases evidence-
based guidelines for the management of acute gastroenteritis in children
in Europe: update 2014. J Pediatr Gastroenterol Nutr 2014;59:132-52.
3. Valois S, Costa-Ribeiro H Jr, Mattos A, Ribeiro TC, Mendes CM, Lifshitz
F. Controlled, double-blind, randomized clinical trial to evaluate the impact
of fruit juice consumption on the evolution of infants with acute diar-
rhea. Nutr J 2004;4:23-30.
E-cigarette use associated with
tobacco smoking
Leventhal AM, Strong DR, Kirkpatrick MG, Unger JB, Sussman
S, Riggs NR, et al. Association of Electronic Cigarette Use With
Initiation of Combustible Tobacco Product Smoking in Early
Adolescence. JAMA 2015;314:700-7.
Question Among young adolescents, what is the association
of electronic cigarette (e-cigarette) use with subsequent tobacco
smoking initiation?
Design Prospective cohort.
Setting Ten public high schools in Los Angeles, California.
Participants Ninth grade students.
Intervention Self-report survey, repeated at 6- and 12-
month follow-up.
Outcomes Combustible tobacco initiation.
Main Results E-cigarette use was associated with subsequent
combustible tobacco product initiation, OR, 2.73 (95% CI,
2.00-3.73, adjusted for sociodemographic, environmental, and
intrapersonal risk factors for smoking).
Conclusions Among young adolescents, e-cigarette use was as-
sociated with subsequent combustible tobacco product
initiation.
Commentary This longitudinal cohort study found that base-
line e-cigarette use was associated with increased likelihood
of combustible tobacco initiation. This study garnered wide-
spread attention in the tobacco control community, as prior
evidence largely used cross-sectional data that cannot estab-
lish causality or temporal patterns of use.1 Despite the longi-
tudinal design, the data do not establish causality and instead
may reflect a general tendency for tobacco product users to
try other tobacco products, instead of a unique tendency in
e-cigarette users. A strength of this study is the persistence of
the findings with adjustment for multiple confounders that have
previously been shown to heighten risk of tobacco use. Ad-
ditionally, it informs the public health debate regarding
e-cigarettes, which weighs the potential benefits of smoking
cessation in adults with the potential that e-cigarettes promote
cigarette initiation and adverse health outcomes in adoles-
cents. The study’s findings have now been replicated,2 and this
growing evidence base highlights our duty to carefully con-
sider the protection of youth when formulating e-cigarette poli-
cies and regulations.
Deepa Camenga, MD, MHS
Yale School of Medicine
New Haven, Connecticut
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Adolescent BMI greater than 50% is
associated with adult cardiovascular-death
risk
Twig G, Yaniv G, Levine H, Leiba A, Goldberger N, Derazne
E, et al. Body-Mass Index in 2.3 Million Adolescents and
Cardiovascular Death in Adulthood. N Engl J Med
2016;374:2430-40.
Question What is the association of adult cardiovascular death
(CVD) among obese adolescents, compared with adolescents
who are not obese?
Design Retrospective, longitudinal data-set analysis.
Setting Israel.
Participants Jewish Israeli adolescents, 16-19 years old.
Intervention Body-mass index (BMI).
Outcomes CVD.
Main Results Multivariable analysis noted graded CVD risk
among adolescents in the 50th to 74th percentiles of BMI
(ie, within the accepted normal range). The obese group
compared with those in the 5th to 24th percentiles demon-
strated increased CVD risk: adjusted hazard ratio 4.9 (95% CI,
3.9-6.1) for coronary heart disease, 2.6 (95% CI, 1.7-4.1) for
stroke, 2.1 (95% CI, 1.5-2.9) for sudden death, and 3.5 (95%
CI, 2.9-4.1) for all-cause mortality.
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Conclusions BMI grater than 50% was associated with in-
creased CVD risk.
Commentary This large follow-up study of Israeli adoles-
cents found that BMI is virtually log-linearly associated with
CVD and only slight nonlinearity was found for all-cause mor-
tality. This result is more striking because no information on
body-composition was available, and even more so because un-
derweight males may have a low level of muscle mass. Why
are the results so different from results in middle-aged popu-
lations, suggesting that normal weight, or even slight over-
weight, could be associated with lower mortality?1 The obvious
reason is that in this young and healthy population there is
no reverse causality. In a middle-age population, lean persons
are a mixed group of healthy lean persons and persons suf-
fering unintentional weight loss due to disease. This study clearly
shows that there is no “obesity paradox”: a healthy BMI is a
low BMI, with the obvious exception of those having high
muscle mass. Although it may be difficult to accept that many
people in modern Western society suffer the health conse-
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Viral PCR testing associated with decreased
healthcare resource utilization
Subramony A, Zachariah P, Krones A, Whittier S, Saiman L.
Impact of Multiplex Polymerase Chain Reaction Testing for
Respiratory Pathogens on Healthcare Resource Utilization for
Pediatric Inpatients. J Pediatr 2016;173:196-201.
Question What is the association of viral multiplex poly-
merase chain reaction (mPCR) testing with healthcare re-
source utilization?
Design Retrospective cohort study.
Setting New York-Presbyterian Morgan Stanley Children’s
Hospital.
Participants Hospitalized infants, children, and adolescents
under 18 years of age.
Intervention mPCR testing for viruses or not.
Outcomes Use of antibiotics, chest radiographs, and isola-
tion precautions.
Main Results Multivariable regression demonstrated mPCR
testing decreased the likelihood of antibiotic use ≥2 days, OR,
0.5 (95% CI, 0.5-0.6), chest radiographs at admission, OR, 0.4
(95% CI, 0.3-0.4), and increased the likelihood of isolation for
≥2 days, OR, 2.4 (95% CI, 2.1-2.8) compared with the group
without mPCR.
Conclusions mPCR use was significantly associated with de-
creased healthcare resource utilization and increased isola-
tion precautions.
Commentary This study attempted to demonstrate that imple-
mentation of an mPCR assay resulted in clinical utilization
changes observed pre- and postimplementation. It is crucial
that such quasi-experimental studies identify and control for
external confounders.1 Although the authors provide reassur-
ances, results could be confounded by an apparent increase in
testing observed between the periods. Reassuring details of the
study’s validity include two winter viral seasons were moni-
tored both pre- and postintervention and the prevalence of re-
spiratory syncytial virus and influenza was similar. Antibiotic
utilization did not differ pre- and postintervention in a control
cohort with acute gastroenteritis. Finally, data here are similar
to those of others.2 Overall these data help justify mPCR costs.
Importantly, results were available with “. . .a turnaround time
of approximately 3 hours from order entry to results being
viewed by providers.” Delays in the turnaround of results, due
to specific mPCR test characteristics or laboratory staffing, could
attenuate this impact. Providers should cautiously interpret the
results of mPCR respiratory assays as viral detection may be
prolonged, particularly in young children and in patients with
rhinovirus.3 Important areas for future research include un-
derstanding the impact of these assays on neonates, infection
control outcomes, timely administration of antivirals to pa-
tients with influenza, duration of hospitalization, and hospi-
talization costs.
Evan J. Anderson, MD
Emory University School of Medicine
Atlanta, Georgia
References
1. Harris AD, McGregor JC, Perencevich EN, Furuno JP, Zhu J, Peterson DE,
et al. The use and interpretation of quasi-experimental studies in medical
informatics. J Am Med Inform Assoc 2006;13:16-23.
2. Rogers BB, Shankar P, Jerris RC, Kotzbauer D, Anderson EJ, Watson JR,
et al. Impact of a rapid respiratory panel test on patient outcomes. Arch
Pathol Lab Med 2015;139:636-41.
3. Byington CL, Ampofo K, Stockmann C, Adler FR, Herbener A, Miller T,
et al. Community surveillance of respiratory viruses among families in the
Utah Better Identification of Germs-Longitudinal Viral Epidemiology (BIG-
LoVE) Study. Clin Infect Dis 2015;61:1217-24.
Early allergenic-food introduction does not
reduce subsequent food allergy development
Perkin MR, Logan K, Tseng A, Raji B, Ayis S, Peacock J, et al.
Randomized Trial of Introduction of Allergenic Foods in Breast-
Fed Infants. N Engl J Med 2016;374:1733-43.
Question Does early allergenic-food introduction to infants
reduce later allergy development?
Design Randomized, controlled trial.
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Setting Single site in the United Kingdom.
Participants Exclusively breast-fed infants who were 3 months
of age.
Intervention Six allergenic foods (peanut, cooked egg, cow’s
milk, sesame, whitefish, and wheat) introduced, one at a time,
between 3-6 months of age versus no introduction.
Outcomes Food allergy to one or more of the six foods between
1-3 years of age.
Main Results Intention-to-treat analysis did not detect a dif-
ference in food-allergy development: absolute risk reduction
1.5% (95% CI, −1.3%-4.3%).
Conclusions Early allergenic-food introduction did not prevent
subsequent food allergy.
Commentary The study by Perkin et al provides some
insight as to what age allergenic-foods should be introduced
to an infant’s diet. Avoiding the early introduction of aller-
genic foods is feasible (97.4% in the control group did not
consume any allergenic food before 5 months). Early, massive
allergenic-food introduction is difficult (only 42.3% in the
early-introduction group consumed at least 5 of the aller-
genic foods in adequate amounts between 3 and 6 months of
age). Early introduction, based on per-protocol (not intention-
to-treat) analysis may reduce the incidence of allergy to
some foods (eggs and peanuts) but not to all. Despite some
unavoidable methodologic limitations (selection, detection
and attrition), the Enquiring about Tolerance (EAT), Perkin
et al, trial seems to cool enthusiasm aroused by the Learning
Early About Peanut allergy study that, on the model of
peanut introduction, early introduction of any food may
reduce the frequency of subsequent allergy to that particular
food.1 Additional studies, from different countries, climates,
and culinary traditions, among infants in different risk cat-
egories may enhance the dataset from which we provide
solid food introduction guidelines. These studies are much
needed, as food allergy appears to be rising. The EAT trial
noted a 5.4% hen-egg allergy prevalence in the control
group, exceeding that reported (2.2%) in an epidemiologic
UK study.2
Alessandro Fiocchi, MD
Pediatric Hospital Bambino Gesù
Holy See, Rome, Italy
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